News story: Veterinary medicines – information about market access during the implementation period following EU exit

image_pdfimage_print

The joint guidance published on 6 August outlines what it would mean for market access for medicines during the implementation period, including; licensing and packaging, batch release and testing, and the UK regulatory role.

It also covers other points relating to medicines and implementation plans related to EU legislation during the implementation period.

Leave a Reply

Your email address will not be published.